Abionyx Pharma Pursues Regulatory Steps for LCAT Deficiency and Phase 2b Sepsis Trial
Abionyx Pharma is pursuing regulatory steps for LCAT deficiency and a Phase 2b sepsis trial.
Abionyx Pharma is pursuing regulatory steps for LCAT deficiency and a Phase 2b sepsis trial.